PVI
MYOK

Pura Vida Investments’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Pura Vida Investments’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-28,800
Closed -$2.78M – 192
2020
Q2 		$2.78M Buy
+28,800
New +$2.4M 0.27% 79

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Pura Vida Investments's MYOK Position: Q3 2020 in Review

Pura Vida Investments sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 28,800 shares — an estimated $2.78M sold.

Pura Vida Investments first reported a position in MYOK in Q2 2020 and held it in 1 quarter. The position peaked at $2.78M in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • Pura Vida Investments reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Pura Vida Investments sold 28,800 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $2.78M.
  • Pura Vida Investments first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Pura Vida Investments's MyoKardia, Inc. Common Stock position peaked at $2.78M in Q2 2020.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Pura Vida Investments's 13F filing for Q3 2020, filed 16 Nov 2020.